{
    "2021-05-14": [
        [
            {
                "time": "",
                "original_text": "爱美客(300896.SZ)：授权管理层启动H股发行并在联交所上市的相关筹备工作",
                "features": {
                    "keywords": [
                        "爱美客",
                        "H股发行",
                        "联交所",
                        "筹备工作"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗美容",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股医药生物公司研发实力排行榜：恒瑞医药、复星医药、君实生物研发投入居前三，药明康德研发人员数量最多",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "复星医药",
                        "君实生物",
                        "药明康德",
                        "研发投入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "爱美客：聘马乔骞为证代，2017年9月入职",
                "features": {
                    "keywords": [
                        "爱美客",
                        "马乔骞",
                        "证代",
                        "2017年9月"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗美容"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "爱美客：聘任马乔骞为公司证券事务代表",
                "features": {
                    "keywords": [
                        "爱美客",
                        "马乔骞",
                        "证券事务代表"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗美容"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "宋清辉：A股百元股数量缩水只有少部分长期坚挺警惕靠概念炒作",
                "features": {
                    "keywords": [
                        "宋清辉",
                        "A股",
                        "百元股",
                        "概念炒作"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "股市整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医美板块如期分化朗姿股份等趋势股表现较弱",
                "features": {
                    "keywords": [
                        "医美板块",
                        "朗姿股份",
                        "分化",
                        "趋势股"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗美容"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "千亿市值股集体大回调后显分化 华熙生物等个股反弹逾40%",
                "features": {
                    "keywords": [
                        "千亿市值股",
                        "回调",
                        "分化",
                        "华熙生物",
                        "反弹"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗美容",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}